GENETIC SUSCEPTIBILITY LOCI IN GENOME-WIDE ASSOCIATION STUDY OF CLUSTER HEADACHE 135 6 24. Pelzer N, Haan J, Stam AH, et al. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology. 2018;90(7):e575-e582. 25. Krokstad S, Langhammer A, Hveem K, et al. Cohort Profile: the HUNT Study, Norway. Int J Epidemiol. 2013;42(4):968-977. 26. Ferreira MA, Vonk JM, Baurecht H, et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet. 2017;49(12):1752-1757. 27. Cainazzo MM, Tiraferri I, Ciccarese M, et al. O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache. J Headache Pain. 2015;16(Suppl 1):A88. 28. Fan Z, Hou L, Wan D, et al. Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study. J Headache Pain. 2018;19(1):1. 29. Fourier C, Ran C, Zinnegger M, et al. A genetic CLOCK variant associated with cluster headache causing increased mRNA levels. Cephalalgia. 2018;38(3):496-502. 30. Rainero I, Rubino E, Gallone S, et al. Cluster headache is associated with the alcohol dehydrogenase 4 (ADH4) gene. Headache. 2010;50(1):92-98. 31. Zarrilli F, Tomaiuolo R, Ceglia C, et al. Molecular analysis of cluster headache. Clin J Pain. 2015;31(1):52-57. 32. Bulik-Sullivan BK, Loh PR, Finucane HK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291-295. 33. Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. 34. Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856-866. 35. Eising E, Pelzer N, Vijfhuizen LS, et al. Identifying a gene expression signature of cluster headache in blood. Sci Rep. 2017;7:40218. 36. Kogelman LJ, Falkenberg K, Halldorsson GH, et al. Comparing migraine with and without aura to healthy controls using RNA sequencing. Cephalalgia. 2019;39(11):1435-1444. 37. Clogg CC, Petkova E, Haritou A. Statistical Methods for Comparing Regression Coefficients Between Models. 1995;100(5):1261-1293. 38. Visscher PM, Wray NR, Zhang Q, et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet. 2017;101(1):5-22. 39. Anttila V, Winsvold BS, Gormley P, et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet. 2013;45(8):912-917. 40. Komatsu M, Chiba T, Tatsumi K, et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 2004;23(9):1977-1986. 41. Cheon S, Dean M, Chahrour M. The ubiquitin proteasome pathway in neuropsychiatric disorders. Neurobiol Learn Mem. 2019;165:106791. 42. Lipton RB, Stewart WF. Prevalence and impact of migraine. Neurol Clin. 1997;15(1):1-13. 43. Sanchez E, Laplace-Builhe B, Mau-Them FT, et al. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4. Genet Med. 2020;22(3):547-556. 44. Yu HC, Coughlin CR, Geiger EA, et al. Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy. Cold Spring Harb Mol Case Stud. 2016;2(3):a000844. 45. Tondo G, Perani D, Comi C. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration. Dis Markers. 2019;2019:2387614. 46. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190-2191. 47. Winkler TW, Day FR, Croteau-Chonka DC, et al. Quality control and conduct of genomewide association meta-analyses. Nat Protoc. 2014;9(5):1192-1212.
RkJQdWJsaXNoZXIy MTk4NDMw